Presentation Materials on Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 20262/6TDnetPDF(2MB)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Under Japanese GAAP)2/6TDnetPDF(499KB)
Notice Concerning Revisions to Full-Year Consolidated Financial Forecasts for the Fiscal Year Ending March 31, 20262/6TDnetPDF(193KB)
[Update on Disclosed Matter]Status of US Subsidiary Satsuma Pharmaceutical’s Negotiation for Atzumi1/5TDnetPDF(149KB)
Presentation Materials for the First Six Months of the Fiscal Year Ending March 31, 202611/7TDnetPDF(2MB)
Notice Regarding Differences between Consolidated Financial Forecasts and Actual Results for the Six Months Ended September 30, 202511/7TDnetPDF(185KB)
Consolidated Financial Results for the Six Months Ended September 30, 2025 (Under Japanese GAAP)11/7TDnetPDF(573KB)